Scientific Advisors and Consultants

Paul Schechter, MD PhD

SAB Member, Clinical Advisor

Dr. Schechter brings four decades of experience in translational medicine and drug development with proven success in advancing numerous drug candidates through development, clinical trials and regulatory processes. His expertise extends from pharmaceutical development to clinical pharmacology and internal medicine. Following degrees from Columbia University and University of Chicago, he trained in Internal Medicine at Rush Medical School and Georgetown University hospitals and in Clinical Pharmacology at the National Institutes of Health. Subsequently he held major R&D executive positions at Merrell Dow Pharmaceuticals, Fujisawa, Hybridon, MacroChem and Nucryst Pharmaceuticals. At Merrell Dow he was responsible for the development and all clinical testing of DFMO, a component of Aminex’s AMXT 1501/DFMO therapy.


Philippe Bey, PhD

SAB Member, Science Advisor

Philippe Bey, PhD, is currently senior VP of R&D at Thrasos Therapeutics, a private Canadian, clinical-stage biotechnology company. Prior to joining Thrasos Therapeutics, from July 1999 to January 2003, he was CSO and senior VP of R&D of ArQule, a combinatorial chemistry biotechnology company. Previously Dr. Bey was at Hoechst Marion Roussel (HMR), now Sanofi, and its parent companies, from 1971 to 1999. He served in numerous science and management leadership positions both in Europe and the United States. His last position was U.S. senior VP of R&D and member of the HMR management team. During his career, Dr. Bey has participated in and led teams responsible for more than 30 INDs in several therapeutic areas, including oncology. He also was responsible for bulk drug supply for preclinical and clinical studies. Philippe received his BS and PhD in chemistry from the University Louis Pasteur in Strasbourg, France. He was a post-doctoral trainee at the California Institute of Technology for two years and an adjunct professor of medicinal chemistry at the University Louis Pasteur in Strasbourg for twelve years. He has authored nearly 100 publications, 21 book chapters, and holds 63 issued patents. Dr. Bey is the inventor of difluoromethylornithine, (DFMO), the standard of care for African sleeping sickness.


Robert Lewis, MD PhD

SAB Member, Science Advisor

Dr. Lewis is a physician-scientist, who was formerly a faculty member of the Harvard Medical School and Stanford Medical School, President of Discovery Research at Syntex Corp, Head of US R&D at Aventis Pharmaceuticals, and presently a consulting professor at Stanford. He is an independent consultant and a member of several other scientific advisory boards. His principal expertise is in immunology and cell biology.